Evaluation of Atypical Chemokine Receptor Expression in T Cell Subsets

Messias Oliveira Pacheco1, Fernanda Agostini Rocha1, Thiago Pinheiro Arrais Aloia1

  • 1Hospital Israelita Albert Einstein, Rua Comendador Elias Jafet, São Paulo 05652-000, Brazil.

Cells
|December 23, 2022
PubMed

Insights

Atypical chemokine receptors (ACKRs) are expressed in T lymphocyte subsets, primarily intracellularly. Their surface expression and role in inflammation and chemotaxis require further investigation.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Chemokines, small cytokines, regulate cell movement (chemotaxis) via receptors.
  • Atypical chemokine receptors (ACKRs) internalize and degrade chemokines, influencing inflammation.
  • The expression of ACKRs in human T lymphocytes remains poorly understood.

Purpose of the Study:

  • To investigate the expression of atypical chemokine receptors (ACKR2, ACKR3, ACKR4) in human T lymphocyte subpopulations.
  • To determine if ACKR expression differs across naive, transitional, and memory T cells.

Main Methods:

  • Peripheral blood from healthy donors was analyzed.
  • Immunophenotyping was used to detect ACKR2, ACKR3, and ACKR4 expression.
  • Expression was assessed in CD4+, CD8+ T lymphocytes and their naive, transitional, and memory subsets.

Main Results:

  • ACKR2, ACKR3, and ACKR4 were expressed by T lymphocyte subsets in varying proportions.
  • These receptors showed high expression within the cytoplasm of all T lymphocyte subsets.
  • Intracellular localization suggests regulated plasma membrane expression dependent on unknown stimuli.

Conclusions:

  • T lymphocyte subsets express ACKR2, ACKR3, and ACKR4, predominantly intracellularly.
  • Surface expression appears regulated post-transcriptionally, likely stimulus-dependent.
  • ACKR3's scavenger function may not impede ligand chemotaxis via typical receptors.